Literature DB >> 9854044

SCID mice containing muscle with human mitochondrial DNA mutations. An animal model for mitochondrial DNA defects.

K M Clark1, D J Watt, R N Lightowlers, M A Johnson, J B Relvas, J W Taanman, D M Turnbull.   

Abstract

Defects of the mitochondrial genome are important causes of disease. Despite major advances in our investigation of patients, there is no effective therapy. Progress in this area is limited by the absence of any animal models in which we can evaluate treatment. To develop such a model we have injected human myoblasts into the tibialis anterior of SCID mice after inducing necrosis. After injection of normal human myoblasts, regenerating fibers expressed human beta-spectrin, confirming they were derived from fusion of human myoblasts. The stability of the muscle fibers was inferred by demonstrating the formation of motor end plates on the regenerating fibers. In addition, we show the presence of human cytochrome c oxidase subunit II, which is encoded by the mitochondrial genome, in the regenerated fibers. After injection of human myoblasts containing either the A8344G or the T8993C heteroplasmic mitochondrial DNA mutations, human beta-spectrin positive fibers were found to contain the mutation at a similar level to the injected myoblasts. These studies highlight the potential value of this model for the study of mitochondrial DNA defects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9854044      PMCID: PMC509163          DOI: 10.1172/JCI944

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES.

Authors:  M J KARNOVSKY; L ROOTS
Journal:  J Histochem Cytochem       Date:  1964-03       Impact factor: 2.479

Review 2.  Diseases of the mitochondrial DNA.

Authors:  D C Wallace
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

3.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.

Authors:  M P King; G Attardi
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

4.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

5.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria.

Authors:  A Chomyn; G Meola; N Bresolin; S T Lai; G Scarlato; G Attardi
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).

Authors:  L Boulet; G Karpati; E A Shoubridge
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

8.  Length mutations in human mitochondrial DNA: direct sequencing of enzymatically amplified DNA.

Authors:  L A Wrischnik; R G Higuchi; M Stoneking; H A Erlich; N Arnheim; A C Wilson
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

9.  Tissue segregation of a heteroplasmic mtDNA mutation in MERRF (myoclonic epilepsy with ragged red fibers) encephalomyopathy.

Authors:  P Lertrit; A S Noer; E Byrne; S Marzuki
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

10.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts.

Authors:  A Chomyn; A Martinuzzi; M Yoneda; A Daga; O Hurko; D Johns; S T Lai; I Nonaka; C Angelini; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.